25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BUX (BioMark Diagnostics Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze BioMark Diagnostics Inc together

I guess you are interested in BioMark Diagnostics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – BioMark Diagnostics Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – BioMark Diagnostics Inc’s Price Targets

I'm going to help you getting a better view of BioMark Diagnostics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BioMark Diagnostics Inc

I send you an email if I find something interesting about BioMark Diagnostics Inc.

1. Quick Overview

1.1. Quick analysis of BioMark Diagnostics Inc (30 sec.)










1.2. What can you expect buying and holding a share of BioMark Diagnostics Inc? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$-0.01
Expected worth in 1 year
C$-0.02
How sure are you?
23.3%

+ What do you gain per year?

Total Gains per Share
C$-0.01
Return On Investment
-1.9%

For what price can you sell your share?

Current Price per Share
C$0.32
Expected price per share
C$0.28 - C$0.34
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of BioMark Diagnostics Inc (5 min.)




Live pricePrice per Share (EOD)
C$0.32
Intrinsic Value Per Share
C$-0.12 - C$-0.14
Total Value Per Share
C$-0.13 - C$-0.15

2.2. Growth of BioMark Diagnostics Inc (5 min.)




Is BioMark Diagnostics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$808.2k-$736.5k$112.3k18.0%

How much money is BioMark Diagnostics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$349k-$282.9k-$66k-18.9%
Net Profit Margin-1,226.3%-948.5%--

How much money comes from the company's main activities?

2.3. Financial Health of BioMark Diagnostics Inc (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of BioMark Diagnostics Inc?

Welcome investor! BioMark Diagnostics Inc's management wants to use your money to grow the business. In return you get a share of BioMark Diagnostics Inc.

First you should know what it really means to hold a share of BioMark Diagnostics Inc. And how you can make/lose money.

Speculation

The Price per Share of BioMark Diagnostics Inc is C$0.32. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BioMark Diagnostics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BioMark Diagnostics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$-0.01. Based on the TTM, the Book Value Change Per Share is C$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is C$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BioMark Diagnostics Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps0.00-0.8%0.00-1.2%0.00-0.9%0.00-1.1%0.00-1.0%0.00-0.8%
Usd Book Value Change Per Share0.00-0.2%0.00-0.3%0.000.2%0.00-0.1%0.00-0.1%0.00-0.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.2%0.00-0.3%0.000.2%0.00-0.1%0.00-0.1%0.00-0.1%
Usd Price Per Share0.15-0.18-0.20-0.18-0.18-0.14-
Price to Earnings Ratio-13.57--12.48--18.71--14.02--16.56--16.01-
Price-to-Total Gains Ratio-286.17--356.56-180.20--77.21--165.42--116.72-
Price to Book Ratio-16.56--29.03--26.59--30.31--61.20--45.97-
Price-to-Total Gains Ratio-286.17--356.56-180.20--77.21--165.42--116.72-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.235584
Number of shares4244
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (4244 shares)-4.62-1.33
Gains per Year (4244 shares)-18.50-5.31
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-18-280-5-15
20-37-460-11-20
30-55-640-16-25
40-74-820-21-30
50-92-1000-27-35
60-111-1180-32-40
70-129-1360-37-45
80-148-1540-42-50
90-166-1720-48-55
100-185-1900-53-60

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.030.00.00.0%0.030.00.00.0%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%4.016.00.020.0%7.023.00.023.3%7.023.00.023.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.030.00.0%0.00.030.00.0%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%4.016.00.020.0%7.023.00.023.3%7.023.00.023.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of BioMark Diagnostics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.001+112%0.001-182%-0.001-18%0.000-39%0.000-42%
Book Value Per Share---0.012-0.009-23%-0.011-9%-0.009-24%-0.007-40%-0.008-33%
Current Ratio--0.1050.118-11%0.155-32%0.173-39%0.348-70%0.290-64%
Debt To Asset Ratio--2.2521.909+18%2.346-4%1.957+15%1.853+22%5.562-60%
Debt To Equity Ratio----0%-0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--16202718.80020570446.641-21%22627830.099-28%20881158.163-22%20393235.848-21%16656752.565-3%
Eps---0.004-0.005+42%-0.004+9%-0.005+35%-0.004+13%-0.004-5%
Ev To Sales Ratio--105.041132.461-21%138.610-24%139.491-25%150.938-30%141.551-26%
Free Cash Flow Per Share---0.002-0.002+13%-0.003+25%-0.003+33%-0.003+26%-0.002+5%
Free Cash Flow To Equity Per Share--0.001-0.001+204%0.001-48%0.000+335%0.000+136%0.000+106%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.141----------
Intrinsic Value_10Y_min---0.121----------
Intrinsic Value_1Y_max---0.012----------
Intrinsic Value_1Y_min---0.011----------
Intrinsic Value_3Y_max---0.037----------
Intrinsic Value_3Y_min---0.035----------
Intrinsic Value_5Y_max---0.064----------
Intrinsic Value_5Y_min---0.059----------
Market Cap29083584.000+37%18177245.80022380733.891-19%24425668.099-26%22607945.247-20%21676360.498-16%17828844.099+2%
Net Profit Margin---8.681-12.263+41%-9.485+9%-12.708+46%-8.273-5%-5.600-35%
Operating Margin----0%-2.5970%-6.3330%-4.3630%-2.9940%
Operating Ratio--9.31312.641-26%9.914-6%13.006-28%8.475+10%5.769+61%
Pb Ratio-26.490-60%-16.556-29.032+75%-26.593+61%-30.310+83%-61.200+270%-45.969+178%
Pe Ratio-21.719-60%-13.574-12.485-8%-18.710+38%-14.017+3%-16.560+22%-16.005+18%
Price Per Share0.320+38%0.2000.246-19%0.269-26%0.249-20%0.239-16%0.196+2%
Price To Free Cash Flow Ratio-38.299-60%-23.937-28.885+21%-149.746+526%-66.163+176%-43.596+82%-28.059+17%
Price To Total Gains Ratio-457.880-60%-286.175-356.557+25%180.203-259%-77.209-73%-165.424-42%-116.721-59%
Quick Ratio--0.0470.038+22%0.059-21%0.106-56%0.289-84%0.229-80%
Return On Assets---0.382-0.496+30%-0.475+24%-0.472+24%-0.434+14%-0.890+133%
Return On Equity----0%-0%-0%-0%-0%
Total Gains Per Share---0.001-0.001+112%0.001-182%-0.001-18%0.000-39%0.000-42%
Usd Book Value---808271.035-624204.103-23%-736577.303-9%-616873.146-24%-487585.554-40%-539119.751-33%
Usd Book Value Change Per Share---0.001-0.001+112%0.001-182%0.000-18%0.000-39%0.000-42%
Usd Book Value Per Share---0.009-0.007-23%-0.008-9%-0.007-24%-0.005-40%-0.006-33%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--11928441.58115143962.817-21%16658608.519-28%15372708.640-22%15013500.231-21%12262701.239-3%
Usd Eps---0.003-0.004+42%-0.003+9%-0.004+35%-0.003+13%-0.003-5%
Usd Free Cash Flow---139766.098-158170.545+13%-174192.282+25%-185965.286+33%-176171.777+26%-146199.234+5%
Usd Free Cash Flow Per Share---0.002-0.002+13%-0.002+25%-0.002+33%-0.002+26%-0.002+5%
Usd Free Cash Flow To Equity Per Share--0.0000.000+204%0.001-48%0.000+335%0.000+136%0.000+106%
Usd Market Cap21411334.541+37%13382088.35816476696.291-19%17982176.854-26%16643969.291-20%15958136.599-16%13125595.025+2%
Usd Price Per Share0.236+38%0.1470.181-19%0.198-26%0.183-20%0.176-16%0.144+2%
Usd Profit---246456.938-349079.905+42%-282994.176+15%-337722.241+37%-280086.259+14%-236664.570-4%
Usd Revenue--28390.08128533.087-1%30031.254-5%27979.465+1%17517.253+62%18139.134+57%
Usd Total Gains Per Share---0.001-0.001+112%0.001-182%0.000-18%0.000-39%0.000-42%
 EOD+6 -2MRQTTM+19 -14YOY+11 -223Y+13 -205Y+11 -2210Y+11 -22

3.3 Fundamental Score

Let's check the fundamental score of BioMark Diagnostics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-21.719
Price to Book Ratio (EOD)Between0-1-26.490
Net Profit Margin (MRQ)Greater than0-8.681
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.047
Current Ratio (MRQ)Greater than10.105
Debt to Asset Ratio (MRQ)Less than12.252
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.382
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of BioMark Diagnostics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.382
Ma 20Greater thanMa 500.306
Ma 50Greater thanMa 1000.279
Ma 100Greater thanMa 2000.256
OpenGreater thanClose0.320
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About BioMark Diagnostics Inc

Biomark Diagnostics Inc., an oncology focused company, develops cancer diagnostic platform to detect, monitor, and treat cancer. The company invests in and develops liquid biopsy metabolic panel assay for early stage diagnosis of lung cancer. It has a strategic partnership with Rubix LS to develop diagnostic tools to enhance lung cancer screening and improve breast cancer screening program for women with dense breasts. The company was incorporated in 2014 and is headquartered in Richmond, Canada.

Fundamental data was last updated by Penke on 2025-05-29 15:12:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ BioMark Diagnostics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ BioMark Diagnostics Inc to theΒ Diagnostics & Research industry mean.
  • A Net Profit Margin of -868.1%Β means thatΒ $-8.68 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioMark Diagnostics Inc:

  • The MRQ is -868.1%. The company is making a huge loss. -2
  • The TTM is -1,226.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-868.1%TTM-1,226.3%+358.2%
TTM-1,226.3%YOY-948.5%-277.8%
TTM-1,226.3%5Y-827.3%-399.0%
5Y-827.3%10Y-560.0%-267.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-868.1%-5.2%-862.9%
TTM-1,226.3%-7.6%-1,218.7%
YOY-948.5%-2.9%-945.6%
3Y-1,270.8%-14.6%-1,256.2%
5Y-827.3%-4.9%-822.4%
10Y-560.0%-1.0%-559.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ BioMark Diagnostics Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ BioMark Diagnostics Inc to theΒ Diagnostics & Research industry mean.
  • -38.2% Return on Assets means thatΒ BioMark Diagnostics Inc generatedΒ $-0.38 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioMark Diagnostics Inc:

  • The MRQ is -38.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -49.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-38.2%TTM-49.6%+11.4%
TTM-49.6%YOY-47.5%-2.1%
TTM-49.6%5Y-43.4%-6.2%
5Y-43.4%10Y-89.0%+45.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-38.2%-1.1%-37.1%
TTM-49.6%-1.2%-48.4%
YOY-47.5%-0.9%-46.6%
3Y-47.2%-1.1%-46.1%
5Y-43.4%0.1%-43.5%
10Y-89.0%0.3%-89.3%
4.3.1.3. Return on Equity

Shows how efficient BioMark Diagnostics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ BioMark Diagnostics Inc to theΒ Diagnostics & Research industry mean.
  • 0.0% Return on Equity means BioMark Diagnostics Inc generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioMark Diagnostics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--0.7%+0.7%
TTM--0.8%+0.8%
YOY-0.3%-0.3%
3Y--0.9%+0.9%
5Y-0.3%-0.3%
10Y--1.0%+1.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of BioMark Diagnostics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient BioMark Diagnostics Inc is operatingΒ .

  • Measures how much profit BioMark Diagnostics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ BioMark Diagnostics Inc to theΒ Diagnostics & Research industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioMark Diagnostics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-259.7%+259.7%
TTM-5Y-436.3%+436.3%
5Y-436.3%10Y-299.4%-136.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.3%+14.3%
TTM--11.0%+11.0%
YOY-259.7%-0.1%-259.6%
3Y-633.3%0.6%-633.9%
5Y-436.3%4.7%-441.0%
10Y-299.4%4.9%-304.3%
4.3.2.2. Operating Ratio

Measures how efficient BioMark Diagnostics Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • An Operation Ratio of 9.31 means that the operating costs are $9.31 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BioMark Diagnostics Inc:

  • The MRQ is 9.313. The company is inefficient in keeping operating costs low. -1
  • The TTM is 12.641. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ9.313TTM12.641-3.328
TTM12.641YOY9.914+2.727
TTM12.6415Y8.475+4.166
5Y8.47510Y5.769+2.707
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ9.3131.360+7.953
TTM12.6411.299+11.342
YOY9.9141.275+8.639
3Y13.0061.274+11.732
5Y8.4751.277+7.198
10Y5.7691.192+4.577
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of BioMark Diagnostics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if BioMark Diagnostics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • A Current Ratio of 0.10Β means the company has $0.10 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BioMark Diagnostics Inc:

  • The MRQ is 0.105. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.118. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.105TTM0.118-0.013
TTM0.118YOY0.155-0.037
TTM0.1185Y0.348-0.230
5Y0.34810Y0.290+0.058
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1052.192-2.087
TTM0.1182.146-2.028
YOY0.1552.367-2.212
3Y0.1732.449-2.276
5Y0.3482.552-2.204
10Y0.2903.154-2.864
4.4.3.2. Quick Ratio

Measures if BioMark Diagnostics Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ BioMark Diagnostics Inc to theΒ Diagnostics & Research industry mean.
  • A Quick Ratio of 0.05Β means the company can pay off $0.05 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioMark Diagnostics Inc:

  • The MRQ is 0.047. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.038. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.047TTM0.038+0.009
TTM0.038YOY0.059-0.021
TTM0.0385Y0.289-0.251
5Y0.28910Y0.229+0.060
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0471.105-1.058
TTM0.0381.217-1.179
YOY0.0591.354-1.295
3Y0.1061.587-1.481
5Y0.2891.803-1.514
10Y0.2292.178-1.949
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of BioMark Diagnostics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of BioMark Diagnostics IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ BioMark Diagnostics Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 2.25Β means that BioMark Diagnostics Inc assets areΒ financed with 225.2% credit (debt) and the remaining percentage (100% - 225.2%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of BioMark Diagnostics Inc:

  • The MRQ is 2.252. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.909. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.252TTM1.909+0.343
TTM1.909YOY2.346-0.437
TTM1.9095Y1.853+0.057
5Y1.85310Y5.562-3.710
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2520.405+1.847
TTM1.9090.437+1.472
YOY2.3460.398+1.948
3Y1.9570.400+1.557
5Y1.8530.417+1.436
10Y5.5620.443+5.119
4.5.4.2. Debt to Equity Ratio

Measures ifΒ BioMark Diagnostics Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ BioMark Diagnostics Inc to theΒ Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioMark Diagnostics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.592-0.592
TTM-0.584-0.584
YOY-0.598-0.598
3Y-0.718-0.718
5Y-0.692-0.692
10Y-0.650-0.650
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings BioMark Diagnostics Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ BioMark Diagnostics Inc to theΒ Diagnostics & Research industry mean.
  • A PE ratio of -13.57 means the investor is paying $-13.57Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioMark Diagnostics Inc:

  • The EOD is -21.719. Based on the earnings, the company is expensive. -2
  • The MRQ is -13.574. Based on the earnings, the company is expensive. -2
  • The TTM is -12.485. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-21.719MRQ-13.574-8.145
MRQ-13.574TTM-12.485-1.089
TTM-12.485YOY-18.710+6.225
TTM-12.4855Y-16.560+4.075
5Y-16.56010Y-16.005-0.555
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-21.719-0.545-21.174
MRQ-13.574-0.852-12.722
TTM-12.485-0.628-11.857
YOY-18.710-0.132-18.578
3Y-14.0171.934-15.951
5Y-16.5605.834-22.394
10Y-16.00510.198-26.203
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioMark Diagnostics Inc:

  • The EOD is -38.299. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -23.937. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -28.885. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-38.299MRQ-23.937-14.362
MRQ-23.937TTM-28.885+4.949
TTM-28.885YOY-149.746+120.861
TTM-28.8855Y-43.596+14.710
5Y-43.59610Y-28.059-15.537
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-38.299-0.901-37.398
MRQ-23.937-1.306-22.631
TTM-28.885-0.639-28.246
YOY-149.746-0.791-148.955
3Y-66.163-0.503-65.660
5Y-43.596-0.763-42.833
10Y-28.059-1.832-26.227
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ BioMark Diagnostics Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Diagnostics & Research industry mean).
  • A PB ratio of -16.56 means the investor is paying $-16.56Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BioMark Diagnostics Inc:

  • The EOD is -26.490. Based on the equity, the company is expensive. -2
  • The MRQ is -16.556. Based on the equity, the company is expensive. -2
  • The TTM is -29.032. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-26.490MRQ-16.556-9.934
MRQ-16.556TTM-29.032+12.476
TTM-29.032YOY-26.593-2.439
TTM-29.0325Y-61.200+32.167
5Y-61.20010Y-45.969-15.231
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-26.4901.881-28.371
MRQ-16.5561.977-18.533
TTM-29.0322.050-31.082
YOY-26.5932.386-28.979
3Y-30.3102.486-32.796
5Y-61.2003.421-64.621
10Y-45.9694.314-50.283
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets877
Total Liabilities1,975
Total Stockholder Equity-1,098
 As reported
Total Liabilities 1,975
Total Stockholder Equity+ -1,098
Total Assets = 877

Assets

Total Assets877
Total Current Assets159
Long-term Assets717
Total Current Assets
Cash And Cash Equivalents 89
Net Receivables 71
Total Current Assets  (as reported)159
Total Current Assets  (calculated)159
+/-0
Long-term Assets
Property Plant Equipment 680
Long Term Investments 3
Long-term Assets  (as reported)717
Long-term Assets  (calculated)683
+/- 34

Liabilities & Shareholders' Equity

Total Current Liabilities1,520
Long-term Liabilities454
Total Stockholder Equity-1,098
Total Current Liabilities
Accounts payable 476
Total Current Liabilities  (as reported)1,520
Total Current Liabilities  (calculated)476
+/- 1,045
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt547
Long-term Liabilities  (as reported)454
Long-term Liabilities  (calculated)547
+/- 92
Total Stockholder Equity
Total Stockholder Equity (as reported)-1,098
Total Stockholder Equity (calculated)0
+/- 1,098
Other
Capital Stock10,139
Common Stock Shares Outstanding 90,886
Net Invested Capital -1,098
Net Working Capital -1,361
Property Plant and Equipment Gross 1,398



6.2. Balance Sheets Structured

Currency in CAD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
> Total Assets 
300
147
52
150
46
77
35
175
80
743
637
533
490
404
953
758
630
1,391
1,472
1,306
1,008
885
732
723
632
1,349
1,089
1,006
878
877
8778781,0061,0891,3496327237328851,0081,3061,4721,3916307589534044905336377438017535774615052147300
   > Total Current Assets 
300
146
50
148
45
76
33
173
78
741
628
524
484
399
923
731
605
288
499
426
224
190
126
220
219
380
200
172
102
159
1591021722003802192201261902244264992886057319233994845246287417817333764514850146300
       Cash And Cash Equivalents 
284
122
37
131
32
63
20
155
65
725
612
505
455
357
878
682
379
179
383
365
161
134
72
175
168
313
157
141
35
89
8935141157313168175721341613653831793796828783574555056127256515520633213137122284
       Net Receivables 
17
23
13
17
12
12
13
17
12
16
16
19
14
21
27
23
33
32
82
26
29
22
34
24
30
47
43
31
67
71
716731434730243422292682323323272114191616121713121217132317
   > Long-term Assets 
0
0
0
0
0
0
2
2
2
2
9
10
7
6
30
27
25
1,103
973
881
784
694
606
503
414
969
889
834
776
717
7177768348899694145036066947848819731,103252730671092222000000
       Property Plant Equipment 
0
2
2
2
2
2
2
2
2
2
9
6
3
2
27
24
22
1,100
969
877
781
691
589
486
396
951
852
797
738
680
6807387978529513964865896917818779691,10022242723692222222220
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
333333333333333333300000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14
14
0
0
0
0
0
0
00000014140000000000000000000000
> Total Liabilities 
929
946
952
998
1,054
1,176
1,254
1,066
1,084
1,069
1,076
1,086
1,057
1,052
1,032
891
931
1,862
2,107
1,720
1,749
1,755
1,882
1,864
1,784
1,909
1,699
1,656
1,912
1,975
1,9751,9121,6561,6991,9091,7841,8641,8821,7551,7491,7202,1071,8629318911,0321,0521,0571,0861,0761,0691,0841,0661,2541,1761,054998952946929
   > Total Current Liabilities 
929
946
952
998
1,054
1,176
1,254
1,066
1,084
1,069
1,076
1,086
977
952
922
783
825
1,183
1,501
1,212
1,329
1,409
1,664
1,681
1,638
1,363
1,244
1,256
1,458
1,520
1,5201,4581,2561,2441,3631,6381,6811,6641,4091,3291,2121,5011,1838257839229529771,0861,0761,0691,0841,0661,2541,1761,054998952946929
       Short-term Debt 
656
695
0
857
0
0
0
0
0
0
0
0
0
0
0
0
0
0
144
144
229
229
229
229
0
0
0
0
0
0
000000229229229229144144000000000000008570695656
       Short Long Term Debt 
656
695
0
857
0
0
0
0
0
0
0
0
0
0
0
0
0
0
144
144
229
229
325
327
195
196
0
0
0
0
0000196195327325229229144144000000000000008570695656
       Accounts payable 
274
251
160
141
159
167
164
143
131
123
112
70
60
36
27
9
1
30
128
71
44
67
220
227
295
82
144
149
416
476
47641614914482295227220674471128301927366070112123131143164167159141160251274
       Other Current Liabilities 
0
0
792
0
0
0
1,090
923
953
946
0
0
916
0
108
95
0
862
12
11
9
9
0
9
0
0
0
0
0
0
000000909911128620951080916009469539231,09000079200
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
80
100
110
108
106
679
606
509
420
346
217
182
146
547
454
400
454
454
45445440045454714618221734642050960667910610811010080000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
80
100
110
108
106
679
606
509
420
346
217
182
0
0
0
0
0
0
00000018221734642050960667910610811010080000000000000
> Total Stockholder Equity
-629
-799
-900
-848
-1,008
-1,098
-1,219
-891
-1,004
-326
-439
-553
-566
-648
-79
-133
-301
-471
-636
-414
-741
-870
-1,150
-1,141
-1,152
-560
-610
-650
-1,034
-1,098
-1,098-1,034-650-610-560-1,152-1,141-1,150-870-741-414-636-471-301-133-79-648-566-553-439-326-1,004-891-1,219-1,098-1,008-848-900-799-629
   Common Stock
4,096
4,096
4,087
4,087
4,087
4,309
4,198
4,717
4,855
5,520
5,433
5,433
5,541
5,738
6,876
7,121
7,121
7,121
7,121
8,239
8,239
8,239
8,239
8,239
0
0
0
0
0
0
0000008,2398,2398,2398,2398,2397,1217,1217,1217,1216,8765,7385,5415,4335,4335,5204,8554,7174,1984,3094,0874,0874,0874,0964,096
   Retained Earnings -15,351-15,016-14,469-13,450-13,059-12,608-12,397-11,620-11,477-11,065-10,537-10,118-9,315-9,058-8,879-8,591-8,007-7,812-7,625-7,496-7,211-6,538-6,402-6,229-6,158-6,007-5,846-5,736-5,588-5,412
   Capital Surplus 
0
0
0
0
0
700
811
811
811
1,545
1,769
1,781
1,756
1,725
1,632
1,625
1,625
1,625
1,698
1,884
2,085
2,226
2,232
2,268
0
0
0
0
0
0
0000002,2682,2322,2262,0851,8841,6981,6251,6251,6251,6321,7251,7561,7811,7691,54581181181170000000
   Treasury Stock000000000000000000000000000000
   Other Stockholders Equity 
0
0
50
212
212
50
53
-18
-133
-180
-145
-143
-51
-105
3
0
10
97
662
0
0
142
0
750
0
0
0
0
0
0
000000750014200662971003-105-51-143-145-180-133-1853502122125000



6.3. Balance Sheets

Currency in CAD. All numbers in thousands.




6.4. Cash Flows

Currency in CAD. All numbers in thousands.




6.5. Income Statements

Currency in CAD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in CAD. All numbers in thousands.

Gross Profit (+$)
totalRevenue163
Cost of Revenue-0
Gross Profit0163
 
Operating Income (+$)
Gross Profit0
Operating Expense-1,480
Operating Income-1,317-1,480
 
Operating Expense (+$)
Research Development651
Selling General Administrative722
Selling And Marketing Expenses0
Operating Expense1,4801,373
 
Net Interest Income (+$)
Interest Income4
Interest Expense-115
Other Finance Cost-0
Net Interest Income-111
 
Pretax Income (+$)
Operating Income-1,317
Net Interest Income-111
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,427-1,317
EBIT - interestExpense = -115
-1,427
-1,312
Interest Expense115
Earnings Before Interest and Taxes (EBIT)0-1,312
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-1,427
Tax Provision-0
Net Income From Continuing Ops-1,427-1,427
Net Income-1,427
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net1111
 

Technical Analysis of BioMark Diagnostics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of BioMark Diagnostics Inc. The general trend of BioMark Diagnostics Inc is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine BioMark Diagnostics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. BioMark Diagnostics Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BioMark Diagnostics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.33 < 0.34.

The bearish price targets are: 0.285 > 0.28 > 0.28.

Know someone who trades $BUX? Share this with them.πŸ‘‡

BioMark Diagnostics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BioMark Diagnostics Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BioMark Diagnostics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BioMark Diagnostics Inc. The current macd is 0.01070296.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the BioMark Diagnostics Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for BioMark Diagnostics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the BioMark Diagnostics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
BioMark Diagnostics Inc Daily Moving Average Convergence/Divergence (MACD) ChartBioMark Diagnostics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BioMark Diagnostics Inc. The current adx is 15.02.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy BioMark Diagnostics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
BioMark Diagnostics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BioMark Diagnostics Inc. The current sar is 0.3370596.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
BioMark Diagnostics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BioMark Diagnostics Inc. The current rsi is 61.38. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
BioMark Diagnostics Inc Daily Relative Strength Index (RSI) ChartBioMark Diagnostics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BioMark Diagnostics Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the BioMark Diagnostics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
BioMark Diagnostics Inc Daily Stochastic Oscillator ChartBioMark Diagnostics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BioMark Diagnostics Inc. The current cci is 68.05.

BioMark Diagnostics Inc Daily Commodity Channel Index (CCI) ChartBioMark Diagnostics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BioMark Diagnostics Inc. The current cmo is 19.96.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
BioMark Diagnostics Inc Daily Chande Momentum Oscillator (CMO) ChartBioMark Diagnostics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BioMark Diagnostics Inc. The current willr is -33.33333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that BioMark Diagnostics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
BioMark Diagnostics Inc Daily Williams %R ChartBioMark Diagnostics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of BioMark Diagnostics Inc.

BioMark Diagnostics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BioMark Diagnostics Inc. The current atr is 0.0136709.

BioMark Diagnostics Inc Daily Average True Range (ATR) ChartBioMark Diagnostics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BioMark Diagnostics Inc. The current obv is 542,675.

BioMark Diagnostics Inc Daily On-Balance Volume (OBV) ChartBioMark Diagnostics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BioMark Diagnostics Inc. The current mfi is 87.33.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
BioMark Diagnostics Inc Daily Money Flow Index (MFI) ChartBioMark Diagnostics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BioMark Diagnostics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-01-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-21BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

BioMark Diagnostics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BioMark Diagnostics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.382
Ma 20Greater thanMa 500.306
Ma 50Greater thanMa 1000.279
Ma 100Greater thanMa 2000.256
OpenGreater thanClose0.320
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of BioMark Diagnostics Inc with someone you think should read this too:
  • Are you bullish or bearish on BioMark Diagnostics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about BioMark Diagnostics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BioMark Diagnostics Inc

I send you an email if I find something interesting about BioMark Diagnostics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about BioMark Diagnostics Inc.

Receive notifications about BioMark Diagnostics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.